Bliss GVS Pharma
Bliss Gvs Pharma Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Bliss GVS Pharma
Start SIPBliss Gvs Pharma Investment Rating
-
Master Rating:
-
Bliss Gvs Pharma has an operating revenue of Rs. 733.87 Cr. on a trailing 12-month basis. An annual revenue growth of 30% is outstanding, Pre-tax margin of 7% is okay, ROE of 1% is fair but needs improvement. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 41 which is a POOR score indicating inconsistency in earnings, a RS Rating of 39 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 94 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 169 | 139 | 147 | 138 |
| Operating Expenses Qtr Cr | 135 | 112 | 128 | 129 |
| Operating Profit Qtr Cr | 33 | 27 | 19 | 9 |
| Depreciation Qtr Cr | 4 | 4 | 4 | 3 |
| Interest Qtr Cr | 1 | 2 | 2 | 2 |
| Tax Qtr Cr | 11 | 10 | 7 | 7 |
| Net Profit Qtr Cr | 29 | 25 | 25 | 9 |
Bliss Gvs Pharma Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 8
- Bearish Moving Average
- ___
- 8
- 20 Day
- 74.26
- 50 Day
- 73.73
- 100 Day
- 74.48
- 200 Day
- 78.09
- 20 Day
- 73.78
- 50 Day
- 73.14
- 100 Day
- 74.19
- 200 Day
- 75.82
Bliss Gvs Pharma Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 75.7 |
| Second Resistance | 77.41 |
| Third Resistance | 79.8 |
| RSI | 51.3 |
| MFI | 87.33 |
| MACD Single Line | 0.76 |
| MACD | 0.68 |
| Support | |
|---|---|
| First Resistance | 71.6 |
| Second Resistance | 69.2 |
| Third Resistance | 67.5 |
Bliss Gvs Pharma Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 271,613 | 12,507,779 | 46.05 |
| Week | 241,933 | 10,453,942 | 43.21 |
| 1 Month | 550,155 | 12,620,556 | 22.94 |
| 6 Month | 197,509 | 7,993,184 | 40.47 |
Bliss Gvs Pharma Result Highlights
Bliss GVS Pharma Synopsis
NSE-Medical-Generic Drugs
Bliss Gvs Pharma is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 636.36 Cr. and Equity Capital is Rs. 10.37 Cr. for the Year ended 31/03/2022. Bliss GVS Pharma Ltd. is a Public Limited Listed company incorporated on 11/12/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1984PLC034771 and registration number is 034771.| Market Cap | 781 |
| Sales | 593 |
| Shares in Float | 6.86 |
| No of funds | 27 |
| Yield | 0.68 |
| Book Value | 0.9 |
| U/D Vol ratio | 1.8 |
| LTDebt / Equity | 3 |
| Alpha | -0.08 |
| Beta | 0.86 |
Bliss GVS Pharma
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 34.46% | 34.55% | 34.51% | |
| Mutual Funds | ||||
| Insurance Companies | 6.63% | 6.64% | 6.65% | |
| Foreign Portfolio Investors | 16.53% | 16.68% | 17.17% | |
| Individual Investors | 30.73% | 30.57% | 30.15% | |
| Others | 11.65% | 11.56% | 11.52% |
Bliss GVS Pharma Management
| Name | Designation |
|---|---|
| Mr. S R Vaidya | Chairman & Ind.Director |
| Mr. Gagan Harsh Sharma | Managing Director |
| Dr. Vibha Gagan Sharma | Whole Time Director |
| Mrs. Shruti Vishal Rao | Whole Time Director |
| Mr. Santosh Parab | Independent Director |
| Mrs. Shilpa Bhatia | Independent Director |
Bliss Gvs Pharma Forecast
Price Estimates
Bliss Gvs Pharma Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-01-24 | Quarterly Results | |
| 2022-11-07 | Quarterly Results | |
| 2022-08-03 | Quarterly Results | |
| 2022-04-30 | Audited Results & Final Dividend | |
| 2022-01-29 | Quarterly Results |
Bliss GVS Pharma FAQs
What is Share Price of Bliss GVS Pharma ?
Bliss GVS Pharma share price is ₹74 As on 07 February, 2023 | 18:02
What is the Market Cap of Bliss GVS Pharma ?
The Market Cap of Bliss GVS Pharma is ₹772.4 Cr As on 07 February, 2023 | 18:02
What is the P/E ratio of Bliss GVS Pharma ?
The P/E ratio of Bliss GVS Pharma is 8.9 As on 07 February, 2023 | 18:02
What is the PB ratio of Bliss GVS Pharma ?
The PB ratio of Bliss GVS Pharma is 0.9 As on 07 February, 2023 | 18:02